MedPath

The EC90 of Remifentanil Blunting Hemodynamic Changes to Head Fixation

Not Applicable
Completed
Conditions
Brain Tumor
AVM
ICH
Interventions
Registration Number
NCT01489137
Lead Sponsor
Seoul National University Hospital
Brief Summary

The purpose of this study is to estimate the EC90 of remifentanil blunting hemodynamic changes to head fixation in the patients undergoing neurosurgery.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
50
Inclusion Criteria
  • patients undergoing neurosurgery that require head fixation with mayfield head holder
  • patients who agree to our study
Exclusion Criteria
  • patients who don't agree to our study
  • BMI<16.0 or BMI>30
  • cardiovascular disease, pulmonary disease, renal disease
  • alcoholic abuser or drug abuser
  • patients who takes any drug having an influence on cardiovascular system or sympathetic nervous system
  • any use of local anesthetics or drugs which have an influence on cardiovascular system from beginning of induction to peri-fixation period

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
neurosurgery with fixationremifentanil-
Primary Outcome Measures
NameTimeMethod
mean arterial blood pressureperi-fixation periord

mean arterial blood pressure will be recorded at 2 minutes before fixation, 1 minute before fixation, highest value during immediately post-fixation periord, 1 minute after fixation, 2 minutes after fixation, 3 minutes after fixation, 4 minutes after fixation and 5 minutes after fixation.

heart rateperi-fixation periord

heart rate will be recorded at 2 minutes before fixation, 1 minute before fixation, highest value during immediately post-fixation periord, 1 minute after fixation, 2 minutes after fixation, 3 minutes after fixation, 4 minutes after fixation and 5 minutes after fixation.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Seoul National University Hospital

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath